A TSP-1 functional fragment inhibits activation of latent transforming growth factor-β1 derived from rat alveolar macrophage after bleomycin treatment

Experimental and Toxicologic Pathology

Volumn 61, Issue 1, 2009, Pages 67-73

  Chen, Ying ^a   Wang, Xin ^a   Weng, Dong ^a   Tao, Shasha ^a   Lv, Lina ^a   Chen, Jie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Activation; Alveolar macrophage; Bleomycin induced lung injury; Latent transforming growth factor 1; Thrombospondin 1

Indexed keywords

BLEOMYCIN; CD36 ANTIGEN; LATENT TRANSFORMING GROWTH FACTOR BETA 1; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; CYSTEINYL-SERYL-VALYL-THREONYL-CYSTEINYL-GLYCINE; PEPTIDE FRAGMENT; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL CULTURE; CELL SURFACE; CONTROL GROUP; CONTROLLED STUDY; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOFLUORESCENCE; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PROTEIN BINDING; RAT; WISTAR RAT; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; LUNG FIBROSIS; METABOLISM; TOXICITY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD36; BLEOMYCIN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; MACROPHAGES, ALVEOLAR; PEPTIDE FRAGMENTS; PULMONARY FIBROSIS; RATS; RATS, WISTAR; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS; RATTUS NORVEGICUS;

EID: 59249087036     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2008.06.007     Document Type: Article

References (20)

1. Abe M., Oda N., Sato Y., Shibata K., and Yamasaki M. Augmented binding and activation of latent transforming growth factor-beta by a tryptic fragment of latency associated peptide. Endothelium 9 (2002) 25-36
2. Annes J.P., Chen Y., Munger J.S., and Rifkin D.B. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J Cell Biol 165 (2004) 723-734
3. Chen Y., Chen J., Dong J., and Liu W. Antifibrotic effect of interferon gamma in silicosis model of rat. Toxicol Lett 155 (2005) 353-360
4. Cutroneo K.R. Evidence for TGF-beta1 and bleomycin intracellular signaling through autocrine regulation of Smad3 binding to the proximal promoter of the Smad7 gene. J Cell Biochem 97 (2006) 933-939
5. Cutroneo K.R., White S.L., Phan S.H., and Ehrlich H.P. Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression. J Cell Physiol 211 (2007) 585-589
6. Daniel C., Takabatake Y., Mizui M., Isaka Y., Kawashi H., Rupprecht H., et al. Antisense oligonucleotides against thrombospondin-1 inhibit activation of tgf-beta in fibrotic renal disease in the rat in vivo. Am J Pathol 163 (2003) 1185-1192
7. Dhainaut J.F., Charpentier J., and Chiche J.D. Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome. Crit Care Med 31 (2003) S258-S264
8. Khalil N. TGF-beta: from latent to active. Microb Infect 1 (1999) 1255-1263
9. Khalil N., Whitman C., Zuo L., Danielpour D., and Greenberg A. Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J Clin Invest 92 (1993) 1812-1818
10. Khalil N., Corne S., Whitman C., and Yacyshyn H. Plasmin regulates the activation of cell-associated latent TGF-beta 1 secreted by rat AMs after in vivo bleomycin injury. Am J Respir Cell Mol Biol 15 (1996) 252-259
11. Krutzsch H.C., Ribeiro S.M., Roberts D.D., Murphy-Ullrich J.E., and Hugo C. Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo. Kidney Int 65 (2004) 459-468
12. Pittet J.F., Griffiths M.J., Geiser T., Kaminski N., Dalton S.L., Huang X., et al. TGF-β is a critical mediator of acute lung injury. J Clin Invest 107 (2001) 1537-1544
13. Ribeiro S.M., Poczatek M., Schultz-Cherry S., Villain M., and Murphy-Ullrich J.E. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 274 (1999) 13586-13593
14. Singer A.J., and Clark R.A. Cutaneous wound healing. N Engl J Med 341 (1999) 738-746
15. Venkatesan N., Roughley P.J., and Ludwig M.S. Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-beta (1) and interferon-gamma. Am J Physiol Lung Cell Mol Physiol 283 (2002) L806-L814
16. Wang X., Liu T., Chen Y., and Chen J. Cloning of mouse TSR2-3/TSP-1 gene segments and expression and purification of their coding protein fused with GST. J Chin Med Univ 35 (2006) 454-457 [in Chinese]
17. Xaubet A., Marin-Arguedas A., Lario S., Ancochea J., Morell F., Ruiz-Manzano J., et al. Transforming growth factor-β1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168 (2003) 431-435
18. Xu Q., Norman J.T., Shrivastav S., Lucio-Cazana J., and Kopp J.B. In vitro models of TGF-{beta}-induced fibrosis suitable for high-throughput screening of anti-fibrotic agents. Am J Physiol Renal Physiol 293 (2007) F631-F640
19. Yehualaeshet T., O'Connor R., Green-Johnson J., Mai S., Silverstein R., Murphy-Ullrich J.E., et al. Activation of rat alveolar macrophage-derived latent transforming growth factor-β1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am J Pathol 155 (1999) 841-851
20. Yehualaeshet T., O'Connor R., Begleiter A., Murphy-Ullrich J.E., Silverstein R., and Khalil N. A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat. Am J Respir Cell Mol Biol 23 (2000) 204-212